INNOVATIVE NEBULIZER SYSTEM WITH EXPIRATORY FILTER DESIGNED TO MITIGATE HEALTHCARE WORKERS’ EXPOSURE TO COVID-19
Circulaire® II High-Efficiency Drug Delivery System from Westmed optimizes medication delivery, while reducing caregiver exposure to pathogens like the coronavirus.
Tucson, AZ…In today’s unprecedented challenge to protect healthcare workers on the front lines as they battle the coronavirus pandemic, one Arizona company is providing a unique nebulizer system that is designed to optimize aerosol therapy and mitigate caregiver exposure to the contagion.
Westmed, Inc., a leader in pulmonary medication delivery, introduced the original Circulaire Aerosol Drug Delivery System in 1997. In 2008, the company modified the Circulaire II with new features to create a quasi-closed device that significantly improved drug delivery performance, as well as the safety of the system.
One enhancement included a unique Medication Reservoir, designed to retain the excess aerosol produced during nebulization which would subsequently be inhaled by the patient during inspiration, thus providing maximum output delivery of the nebulizer. As a result, only the Circulaire II System effectively doubles the dosage of medication with every breath.
In addition to functioning as a holding chamber, conserving medication and enhancing aerosol delivery, the Reservoir also prevents room air dilution of medication to achieve the highest Fraction of Inhalable Aerosol in the industry. In fact, multiple studies confirm, the Circulaire System delivers more drug mass in less time than any other conventional nebulizer. Plus, a One-Way Valve virtually eliminates the risk of the patient re-breathing into the nebulizer, to protect the nebulizer and the Reservoir from contamination by exhaled pathogens.
Further, of particular importance today, while not a complete solution, an integral Exhalation Filter in the Circulaire II, with 99.99% bacterial and viral efficiencies, mitigates exposure to exhaled patient droplets and medication during aerosol therapy. The Circulaire II is the only aerosol delivery system available that includes an integral Exhalation Filter as a standard feature.
Westmed, Inc., Receives Innovative Technology Contract from Vizient for Comfort Soft Plus Technology/Cannulas
Tucson, Arizona, February 15, 2020 – Westmed, Inc. announced its Comfort Soft Plus Technology/Cannulas has received an Innovative Technology contract from Vizient, Inc. the largest member-driven health care performance improvement company in the country. The contract was based on a recommendation of Comfort Soft Plus Technology by hospital experts in this category who serve on one of Vizient’s member-led councils.
Westmed’s Comfort Soft Plus Cannulas are designed with proprietary soft elastic properties eliminating device related pressure sores which can be expensive to treat, reduces clinician time monitoring and treating sores and increases patient satisfaction. In addition, the cannulas remain stationary reducing incidents of hypoxemia.
“Westmed is the ﬁrst company to provide a total solution for maximizing patient comfort while virtually eliminating ear and facial pressure ulceration with the new family of Comfort Soft Plus® nasal oxygen cannulas! Ear ulceration escalates from stage 1 to stage 4 due to the anatomy of the skin cartilage structure. These types of ulceration require preventative intervention. The expense of skin breakdown that is associated with standard “PVC” nasal cannulas is now preventable by choosing cannulas and tubing from Westmed’s new proprietary material and revolutionary development in materials science”.
Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents approximately $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to review potentially innovative products. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.
Westmed Inc. is a Tucson based global market leader in the development, manufacture, and distribution of specialized Respiratory Care and Anesthesia products from neonatal to adult patients. Product focus is in Pulmonary Medication Delivery, Oxygen Delivery, Wound Care, Airway Management, Gas Delivery, Humidification Systems inclusive of both passive and active products, Arterial Blood Collection products, and Resuscitation products.
Westmed Inc. Expands Neonatal Respiratory Business with Acquisition of Airways Development, LLC
DECEMBER 2016 — Tucson, AZ — Westmed Inc., a leading manufacturer of respiratory care and anesthesia products, has announced the acquisition of Airways Development, LLC. The deal strengthens Westmed’s presence in the neonatal respiratory care market with unique accessories that align with Westmed’s Neopod™ “T” portable transport humidification system and its Pressure Safe™ high flow nasal cannula with integral safety pressure relief.
Airways Development was founded in 1995 with the launch of their first product line WaterPAP,™ which provides more accuracy and ease-of-use when implementing bubble CPAP in the NICU. In recent years, the company has brought to market innovations in cannula securement for neonates and infants with the Capette,™ Strapette™ and Septal-H™ product lines.
Acquiring the Kenilworth, NJ-based Airways Development, LLC adds an east coast location for processing and distribution of Westmed products. The Airways facility in New Jersey has been expanded to accommodate an increase in production as well as providing an east coast distribution center.
“Having distribution on both sides of the country fits right into our growth plans,” says Jon McKinnon, CEO of Westmed.
Early 2017 will see Westmed launching the Airways product line nationwide, following with international distribution in the spring.
“We’ve seen a lot of traction with our new products, and with the support of Westmed resources in sales and distribution, we believe there is a tremendous opportunity,” says Robert Landis, Manager of Airways Development. “Our products strive to make the work easier for NICU nurses and RTs, and with Westmed’s help we will be able to get them into more hands than ever before.”
About Westmed Inc.
Westmed, Inc. manufactures a comprehensive line of innovative anesthesia, respiratory therapy and critical care products for hospitals, alternative care sites and international healthcare markets. The Company employs over 1000 people worldwide, with manufacturing, administration and customer service operations headquartered in Tucson, Arizona. More information at http://www.westmedinc.com/
About Airways Development, LLC
Airways Development has been innovating for respiratory therapists and NICU nurses since 1995, beginning with the revolutionary WaterPAP™ line that makes implementing bubble CPAP simple, accurate and cost-effective. The company focuses on developing single-use respiratory products for infants, neonates and tracheostomy patients. More information at http://www.airwaysdevelopment.com
Westmed Employees Donate $5,500 to Disaster Relief
November 17, 2016. Westmed employees in the Tucson Arizona plant, as well as remote employees all over the United States, generously contributed $5,500 to charitable organizations helping victims of the recent flooding in the Southern US, Haiti and the Caribbean Islands due to Hurricane Matthew. Westmed, Inc., which pledged to match the employee’s donation, presented checks of $5,410 and $5,590, respectively, to local officials of the American Red Cross and Catholic Relief Services.
Westmed Chief Financial Officer, Doug Pearson, presents a check for $5,410, from the employees of Westmed, Inc. to Jennifer Camano, Major Gift Officer for the Arizona, New Mexico and El Paso Region of the American Red Cross. Officials of Catholic Relief Services, who received a similar check for $5,590, were unavailable for a photo.